Eli Lilly and Company (LLY) is in Healthcare, Drug Manufacturers - General, based in United States, listed on NYSE. Market cap 1.04T USD. 52-week range 783.85 to 1,292.65 USD. Trailing P/E 39.3. Data as of 2026-10-09.
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type ...